A. Becker

University Hospital of Basel — Switzerland

Psychology · Social Sciences

18h-index1.5kcitations87works6.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Psychedelics and Drug Studies(25), Advanced NMR Techniques and Applications(15), Chemical synthesis and alkaloids(15), Microtubule and mitosis dynamics(13), Lanthanide and Transition Metal Complexes(13)

Publications87 total

Psychedelics distinctly alter brain entropy and complexity compared to psychostimulants
2026Open Access
The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research
Journal of Psychopharmacology·2025· 1 citedOpen Access
Die Effektivität stationärer Behandlung von Psychosen – erste Ergebnisse einer naturalistischen Studie
Der Nervenarzt·2025Open Access
Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants
Clinical Pharmacokinetics·2025· 1 citedOpen Access
Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial
Med·2025· 9 citedOpen Access
Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers
Psychopharmacology·2025Open Access
Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults
JAMA Psychiatry·2025· 7 citedOpen Access
Acute Effects and Pharmacokinetics of <scp>LSD</scp> after Paroxetine or Placebo Pre‐Administration in a Randomized, Double‐Blind, Cross‐Over Phase I Trial
Clinical Pharmacology & Therapeutics·2025· 12 citedOpen Access
Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants
Neuropsychopharmacology·2024· 9 citedOpen Access
Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects
Translational Psychiatry·2024· 16 citedOpen Access
Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants
Translational Psychiatry·2024· 13 citedOpen Access
Effects of selective serotonin reuptake inhibitor pretreatment on the acute response to LSD in healthy participants
Neuroscience Applied·2024Open Access
Safety pharmacology of acute psilocybin administration in healthy participants
Neuroscience Applied·2024· 20 citedOpen Access
The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies
Journal of Psychopharmacology·2023· 18 citedOpen Access
Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants
Neuropsychopharmacology·2023· 35 citedOpen Access
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
Neuropsychopharmacology·2023· 109 citedOpen Access
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants
Translational Psychiatry·2023· 74 citedOpen Access
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants
Neuroscience Applied·2023· 1 citedOpen Access
Acute effects of MDMA and LSD co-administration in healthy participants
Neuroscience Applied·2023Open Access
Safety pharmacology of acute psilocybin administration in healthy participants
Neuroscience Applied·2023· 1 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Matthias E. Liechti(21), Friederike Holze(15), Laura Ley(13), Isabelle Straumann(12), Aaron Klaiber(10), Urs Duthaler(9), Anne Eckert(8), Dino Luethi(8), Nimmy Varghese(7), Sarah Eisenacher(7), Susanne Englisch(7), Mathias Zink(7), Livio Erne(6), Yasmin Schmid(6), Andreas Meyer‐Lindenberg(6), Felix Müller(5), Patrick Vizeli(4), Karolina E. Kolaczynska(4), Jan Thomann(4), Severin B. Vogt(4)